Weber M A, Lopez-Ovejero J A, Drayer J I, Case D B, Laragh J H
Arch Intern Med. 1977 Mar;137(3):284-9.
In 79 patients with essential hypertension, treatment with propranolol hydrochloride and chlorthalidone together produced significantly greater falls in both systolic and diastolic blood pressures than were obtained with either drug alone. There were no differences between patients in the high, normal, and low renin subgroups in their responsiveness to this combination. Although plasma renin level during combined treatment was twice as high as it was in the untreated control, aldosterone excretion actually decreased. These divergent changes may have been influenced by the renin-raising and aldosterone-lowering effects of the marked hypokalemia observed during combined treatment. By comparison with patients whose blood pressures fell, treatment in nonresponding patients produced even greater body weight reductions and significantly higher renin and aldosterone values. It is possible that increased activity of the renin axis, triggered by excessive volume depletion and perhaps by changes in potassium balance, were responsible for sustaining the high levels of blood pressure in those patients failing to respond to treatment.
在79例原发性高血压患者中,盐酸普萘洛尔和氯噻酮联合治疗使收缩压和舒张压下降幅度明显大于单药治疗。高肾素、正常肾素和低肾素亚组患者对这种联合治疗的反应性无差异。虽然联合治疗期间血浆肾素水平是未治疗对照组的两倍,但醛固酮排泄实际上却减少了。这些不同的变化可能受到联合治疗期间观察到的明显低钾血症的升肾素和降醛固酮作用的影响。与血压下降的患者相比,无反应患者的治疗导致体重减轻更多,肾素和醛固酮值显著更高。有可能是过度的容量耗竭以及可能的钾平衡变化引发的肾素轴活性增加,导致那些对治疗无反应的患者血压持续处于高水平。